Severe asthma in children

Area of Science:

• Pediatric Pulmonology
• Allergy and Immunology
• Clinical Therapeutics

Background:

• Severe asthma in children presents persistent symptoms, often unresponsive to standard high-dose inhaled or oral corticosteroids.
• Children with severe asthma are categorized into difficult-to-treat or severe therapy-resistant groups.
• Current treatment guidelines for severe childhood asthma largely rely on extrapolated adult data.

Purpose of the Study:

• To highlight the heterogeneity of severe asthma in children, including distinct clinical and inflammatory phenotypes.
• To emphasize the importance of accurate diagnosis and management of contributing factors for difficult-to-treat asthma.
• To advocate for phenotype-targeted therapeutic strategies to improve treatment outcomes.

Main Methods:

• Review of current understanding and classification of severe asthma in pediatric populations.
• Analysis of diagnostic challenges and adherence issues contributing to difficult-to-treat asthma.
• Examination of current guideline-based pharmacotherapy and its limitations.

Main Results:

• Severe asthma is heterogeneous, with identifiable phenotypes in children.
• Difficult-to-treat asthma stems from misdiagnosis, comorbidities, or psychosocial/environmental factors.
• Therapy-resistant asthma is defined by poor control despite addressing these factors.

Conclusions:

• Accurate diagnosis and management of contributing factors are crucial for controlling difficult childhood asthma.
• Phenotypic characterization is essential for tailoring effective therapeutic interventions.
• Future improvements in severe pediatric asthma treatment depend on personalized, phenotype-based approaches.